Crowley Elizabeth has filed 16 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 85000 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | A | Incentive Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 66,383 | 9999.99% | 100.00% |
| June 14, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Common Stock | 30000 | $10.38 | 39,074.0000 | 58,871 | 330.61% | 50.96% |
| June 14, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | S | Common Stock | 30000 | $34.87 | 9,074.0000 | 58,871 | 76.78% | 50.96% |
| June 14, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Incentive Stock Option (Right to Buy) | 30000 | $0.00 | 46,500.0000 | 58,871 | 39.22% | 50.96% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | A | Incentive Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 58,871 | 9999.99% | 100.00% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Common Stock | 7500 | $10.38 | 16,574.0000 | 58,871 | 82.65% | 12.74% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Common Stock | 7500 | $9.02 | 24,074.0000 | 58,871 | 45.25% | 12.74% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | S | Common Stock | 15000 | $35.06 | 9,074.0000 | 58,871 | 62.31% | 25.48% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Incentive Stock Option (Right to Buy) | 7500 | $0.00 | 76,500.0000 | 58,871 | 8.93% | 12.74% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Incentive Stock Option (Right to Buy) | 7500 | $0.00 | 0.0000 | 58,871 | 100.00% | 12.74% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Common Stock | 34445 | $2.78 | 39,171.0000 | 58,871 | 728.84% | 58.51% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Common Stock | 8500 | $9.02 | 47,671.0000 | 58,871 | 21.70% | 14.44% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | S | Common Stock | 38597 | $33.64 | 9,074.0000 | 58,871 | 80.97% | 65.56% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Incentive Stock Option (Right to Buy) | 34445 | $0.00 | 0.0000 | 58,871 | 100.00% | 58.51% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP & CPDO | M | Incentive Stock Option (Right to Buy) | 8500 | $0.00 | 7,500.0000 | 58,871 | 53.13% | 14.44% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Crowley Elizabeth | SR. VP &CPDO | A | Incentive Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 47,214 | 9999.99% | 100.00% |